• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类乳腺肿瘤中的SR蛋白表达及CD44剪接模式

SR protein expression and CD44 splicing pattern in human breast tumours.

作者信息

Pind Molly T, Watson Peter H

机构信息

Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Man., Canada.

出版信息

Breast Cancer Res Treat. 2003 May;79(1):75-82. doi: 10.1023/a:1023338718974.

DOI:10.1023/a:1023338718974
PMID:12779084
Abstract

Altered gene expression during breast tumour progression can occur through alternative splicing of mRNAs. The SR proteins have been identified as important factors in RNA splicing and in the incorporation of alternative exons in experimental systems. We have studied SR protein expression by western blot in human breast cell lines and in a cohort of 101 invasive breast tumours to examine the relationship with alternatively spliced isoforms of the CD44 gene. Multiple SR proteins (SR75, 55, 40, 30) were expressed in most cell lines and tumours, and their relative expression was independent of grade, size, or nodal status. Higher relative expression of SR55 protein was associated with an altered pattern of CD44 variants incorporating exon v7 (p = 0.047) as determined by reverse transcription-polymerase chain reaction (RT-PCR) and Southern blot analysis. Nevertheless, transient transfection of MCF7 and HBL100 breast cell lines with SR55 had no direct effect on the expression of CD44 v7 variant expression. We conclude that while SR proteins may be important and necessary factors in mRNA splicing, other factors are also necessary to influence the regulation of alternatively spliced isoforms of CD44.

摘要

在乳腺肿瘤进展过程中,基因表达的改变可通过mRNA的可变剪接发生。SR蛋白已被确定为RNA剪接以及在实验系统中可变外显子掺入的重要因素。我们通过蛋白质免疫印迹法研究了人乳腺细胞系和101例浸润性乳腺肿瘤队列中的SR蛋白表达,以检查其与CD44基因可变剪接异构体的关系。多种SR蛋白(SR75、55、40、30)在大多数细胞系和肿瘤中表达,其相对表达与分级、大小或淋巴结状态无关。通过逆转录-聚合酶链反应(RT-PCR)和Southern印迹分析确定,SR55蛋白的相对高表达与包含外显子v7的CD44变体模式改变有关(p = 0.047)。然而,用SR55瞬时转染MCF7和HBL100乳腺细胞系对CD44 v7变体表达没有直接影响。我们得出结论,虽然SR蛋白可能是mRNA剪接中的重要且必要的因素,但其他因素对于影响CD44可变剪接异构体的调控也是必需的。

相似文献

1
SR protein expression and CD44 splicing pattern in human breast tumours.人类乳腺肿瘤中的SR蛋白表达及CD44剪接模式
Breast Cancer Res Treat. 2003 May;79(1):75-82. doi: 10.1023/a:1023338718974.
2
CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.CD44可变剪接与hnRNP A1表达与乳腺癌转移相关。
Oncol Rep. 2015 Sep;34(3):1231-8. doi: 10.3892/or.2015.4110. Epub 2015 Jul 6.
3
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.CD44 异构体在乳腺癌中呈异质性表达,并与肿瘤亚型和癌症干细胞标志物相关。
BMC Cancer. 2011 Sep 29;11:418. doi: 10.1186/1471-2407-11-418.
4
Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA.磷酸化可稳定乳腺癌细胞中可变剪接的CD44 mRNA转录本:酪蛋白激酶II mRNA反义互补序列的抑制作用。
Mol Cell Biochem. 1998 Oct;187(1-2):23-31. doi: 10.1023/a:1006865721693.
5
CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.乳腺和结肠肿瘤中CD44的表达模式:基于PCR的剪接变体研究
Int J Cancer. 1995 Oct 20;64(5):347-54. doi: 10.1002/ijc.2910640512.
6
Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.剪接因子Tra2-β1在乳腺癌中特异性诱导表达,并调控CD44基因的可变剪接。
Cancer Res. 2006 May 1;66(9):4774-80. doi: 10.1158/0008-5472.CAN-04-3294.
7
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.乳腺肿瘤发生过程中SR剪接因子和可变剪接的阶段特异性变化。
Oncogene. 1999 Jun 17;18(24):3574-82. doi: 10.1038/sj.onc.1202671.
8
CD44 variant expression and estrogen receptor status in breast cancer.乳腺癌中CD44变异体表达与雌激素受体状态
Breast Cancer Res Treat. 1997 Apr;43(2):165-73. doi: 10.1023/a:1005797030963.
9
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.人结肠腺癌中异质性核糖核蛋白和SR因子的表达改变。
Cancer Res. 1998 Dec 15;58(24):5818-24.
10
Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.细胞粘附分子CD44的可变剪接变体与结直肠癌的肿瘤进展
Br J Cancer. 1996 Aug;74(3):342-51. doi: 10.1038/bjc.1996.364.

引用本文的文献

1
Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.剪接因子在乳腺转化和乳腺癌转移中的差异功能。
Cell Rep. 2019 Nov 26;29(9):2672-2688.e7. doi: 10.1016/j.celrep.2019.10.110.
2
A summary of relationships between alternative splicing and breast cancer.可变剪接与乳腺癌之间关系的综述。
Oncotarget. 2017 May 9;8(31):51986-51993. doi: 10.18632/oncotarget.17727. eCollection 2017 Aug 1.
3
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.
剪接因子 SRSF1 通过调控细胞凋亡和增殖促进乳腺上皮细胞转化。
Nat Struct Mol Biol. 2012 Jan 15;19(2):220-8. doi: 10.1038/nsmb.2207.
4
Alternative splicing and tumor progression.可变剪接与肿瘤进展。
Curr Genomics. 2008 Dec;9(8):556-70. doi: 10.2174/138920208786847971.
5
Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones.通过调节SRPK1与分子伴侣的动力学相互作用来调控SR蛋白磷酸化和可变剪接。
Genes Dev. 2009 Feb 15;23(4):482-95. doi: 10.1101/gad.1752109.